glp 1 parkinson's disease and neuroprotection Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's Diseases | CNS Drugs GLP-1 Drugs and Parkinson's Disease:

Healthy controls (but not schizophrenia or major depression subjects) demonstrated a significant Glu increase (3.2%)

The frequency of passing stool tended to increase with treatment for 3 months (from 4.2 0.5 times/week to 4.8 0.5 times/week

There are no strictly forbidden foods, but many people find it helpful to limit: Highly processed foods High-sugar snacks and beverages Very high-fat meals may worsen nausea Large portions that may increase digestive discomfort The goal isnt perfection

2021;45(10):e13938

Parisotto EB, Garlet TR, Cavalli VL, Zamoner A, da Rosa JS, Bastos J, et al

Tham kho kin bc s trc khi dng, nu bn ang dng thuc khc hoc ang iu tr ti bnh vin